Product How it works Pricing Blog FAQ About Contact
Black Diamond Therapeutics

Black Diamond Therapeutics (NASDAQ: BDTX) revenue

Black Diamond Therapeutics reported revenue of $70.0m for fiscal 2025; in fiscal 2024 it was $0.0m.

Fiscal 2025 is the highest of the 5 fiscal years on record for Black Diamond Therapeutics.

Revenue, in millions of US dollars0.020180.020190.020200.0202470.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$70.0m—$12.5m17.9%
2024$0.0m—−$78.8m—
2020$0.0m—−$69.6m—
2019$0.0m—−$29.3m—
2018$0.0m—−$8.9m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Black Diamond Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, Black Diamond Therapeutics ranks 313th of the 422 US health care companies with a page on Celsmar.

RankCompanyRevenueRevenue growth
311thViridian Therapeutics$70.8m23,359.9%
312thCodexis$70.4m18.6%
313thBlack Diamond Therapeutics$70.0m—
314thPersonalis$69.6m−17.7%
315thVir Biotechnology$68.6m−7.6%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Black Diamond Therapeutics

How much revenue did Black Diamond Therapeutics make in fiscal 2025?
Black Diamond Therapeutics reported revenue of $70.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
What was the best year for revenue at Black Diamond Therapeutics?
Of its last 5 fiscal years, fiscal 2025, with $70.0m.
Where does Black Diamond Therapeutics rank in its sector by revenue?
It ranks 313th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Black Diamond Therapeutics come from?
From the annual report (Form 10-K) that Black Diamond Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Black Diamond Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2020 · 2019 · 2018. More on Black Diamond Therapeutics: the Black Diamond Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.